BDBM50297600 CHEMBL564065::N-benzyl-1-(cyclopropylmethyl)-N-methyl-2-neopentyl-6,7-dihydro-1H-imidazo[4,5-c]pyridine-5(4H)-carboxamide
SMILES: CN(Cc1ccccc1)C(=O)N1CCc2c(C1)nc(CC(C)(C)C)n2CC1CC1
InChI Key: InChIKey=TXZUNXUVCNXSRI-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50297600 (CHEMBL564065 | N-benzyl-1-(cyclopropylmethyl)-N-me...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 523 | n/a | n/a | n/a | n/a |
Pfizer Discovery Chemistry Curated by ChEMBL | Assay Description Agonist activity at human recombinant CB2 receptor expressed in CHO cells assessed as inhibition forskolin-induced cAMP release | Bioorg Med Chem Lett 19: 4406-9 (2009) Article DOI: 10.1016/j.bmcl.2009.05.062 BindingDB Entry DOI: 10.7270/Q28G8KRV | |||||||||||
More data for this Ligand-Target Pair |